ESC/ERS guidelines: recommendations for pulmonary hypertension (PH) due to left heart disease
| Statement | Class# | Level¶ |
| The optimal treatment of the underlying left heart disease is recommended in patients with PH due to left heart disease | I | C |
| Patients with “out of proportion” PH due to left heart disease (table 3) should be enrolled in RCTs targeting PH specific drugs | IIa | C |
| Increased left-sided filling pressures may be estimated by Doppler echocardiography | IIb | C |
| Invasive measurements of Ppcw or LV end-diastolic pressure may be required to confirm the diagnosis of PH due to left heart disease | IIb | C |
| RHC may be considered in patients with echocardiographic signs suggesting severe PH in patients with left heart disease | IIb | C |
| The use of PAH specific drug therapy is not recommended in patients with PH due to left heart disease | III | C |
RCT: randomised controlled trial; Ppcw: pulmonary capillary wedge pressure; LV: left ventricular; RHC: right heart catheterisation; PAH: pulmonary arterial hypertension. #: class of recommendation; ¶: level of evidence. Reproduced from 1 with permission from the publisher.